Skip to main content

American Partnership for Eosinophilic Disorders

Atlanta, Georgia·EIN 76-0700153·NTEE H80 · Medical Research·501(c)(3)·Filing year 2024

American Partnership for Eosinophilic Disorders's highest-paid officer, the Executive Director, was reported at $97,921 for 2024 (IRS Form 990), including base pay and other compensation. Reported CEO pay ranged from $93,534 to $97,921 between 2023 and 2024.

Total revenue
$744k
Total assets
$765k
Total expenses
$818k
Reported officers
11

How American Partnership for Eosinophilic Disorders’s pay compares

Compared with Medical Research organizations of similar size in the South Atlantic states.

There were too few similar organizations to compare with, so this group goes beyond Georgia.

In line with peers

Most of the roles American Partnership for Eosinophilic Disorders reports are paid within the middle half of what these Medical Research organizations pay for the same roles.

Show how each role compares

From the officer pay American Partnership for Eosinophilic Disorders reported on its latest IRS Form 990.

APFED IS DEDICATED TO PREVENTING AND CURING EOSINOPHIL-ASSOCIATED DISEASES WHILE ENHANCING THE QUALITY OF LIFE FOR PATIENTS AND FAMILIES. WE ACHIEVE THIS BY PASSIONATELY EMBRACING, SUPPORTING, AND ADVANCING EDUCATION, AWARENESS, RESEARCH, ADVOCACY, AND SUPPORT INITIATIVES FOR T

Executive compensation

Form 990 · Part VII & Schedule J · 1 reported individual · Filing year 2024

Percentile bands compare each position's total pay with the same role at Medical Research organizations of similar size in the South Atlantic states. There were too few similar organizations to compare with, so this group goes beyond Georgia.

Executive Director
25th percentile to median
$98k

Plus 10 unpaid individuals.

Browse compensation in Medical Research →

Top pay as a share of expenses

In 2024, the highest total compensation at American Partnership for Eosinophilic Disorders equaled 12% of the organization's total expenses. The median for medical research organizations is 10%.

This organization (2024)
12%
Sector median
10%
Middle half of sector
4% to 21%

Based on 1,115 medical research organizations, each measured at its most recent filing year with reported expenses and compensation.

Funded by

Private foundations whose Form 990-PF Part XV grants matched this organization.

Up 5%
from 2023

From $94k in 2023 to $98k in 2024.

$94k
2023
$98k
2024
Pay for the position

Chief Executive Officer pay rose 5% from 2023 to 2024, while revenue fell 4%.

$94k in 2023 to $98k in 2024.

Pay for the position itself, not any one person. The officeholder may have changed between 2023 and 2024.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Common questions about American Partnership for Eosinophilic Disorders

What does the Chief Executive Officer of American Partnership for Eosinophilic Disorders earn?

In 2024, the Chief Executive Officer of American Partnership for Eosinophilic Disorders received $97,921 in total compensation. This pay is below the median (the midpoint) for Chief Executive Officer roles among Medical Research organizations of similar size in the South Atlantic states, but above the bottom quarter of comparable filings. Based on IRS Form 990 data.

How does Chief Executive Officer pay at American Partnership for Eosinophilic Disorders compare with similar nonprofits?

Compared with the same role at Medical Research organizations of similar size in the South Atlantic states, the 2024 pay of the Chief Executive Officer at American Partnership for Eosinophilic Disorders falls between the 25th percentile and the median. In 2024, the highest total compensation at American Partnership for Eosinophilic Disorders equaled 12% of the organization's total expenses. The median for medical research organizations is 10%.

What are American Partnership for Eosinophilic Disorders's revenue and expenses?

In 2024, American Partnership for Eosinophilic Disorders reported $744k in total revenue and $818k in total expenses on its IRS Form 990.